CGTX vs GILD: Which Stock is Better?
Side-by-side comparison of Cognition Therapeutics Inc and Gilead Sciences Inc in 2026
CGTX
Cognition Therapeutics Inc
$1.11
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | CGTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $97.40M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze CGTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGTX or GILD a better investment?
Comparing CGTX and GILD: Cognition Therapeutics Inc has a market cap of $97.40M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGTX and GILD?
CGTX (Cognition Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGTX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGTX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for CGTX.
Which company is more profitable: CGTX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for CGTX.
Which is the larger company: CGTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $97.40M for CGTX.
Should I buy CGTX or GILD in 2026?
Both CGTX and GILD have investment merit. CGTX trades at $1.11 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGTX and GILD stock?
Key differences: Market Cap ($97.40M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).